Immune response and effect of adenovirus-mediated human BMP-2 gene transfer on the repair of segmental tibial bone defects in goats
Open Access
- 1 January 2005
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 76 (5) , 637-646
- https://doi.org/10.1080/17453670510041709
Abstract
Tissue-engineered bone may be used for filling bone defects. There are, however, no reports on this technique used in large animals. We evaluated the effectiveness of, and immune response in repairing diaphyseal bone defects by gene transfer using bone morphogenetic proteins (BMPs). We used adenovirus-mediated human BMP-2 (Adv-hBMP-2) gene-transduced bone marrow stromal cells (BMSCs) to repair 2.1-cm segmental tibial bone defects in goats (group I, n = 7). An Adv-ssgal-transduced BMSC group (group II, n = 5), a non-transduced BMSC group (group III, n = 5), and an untreated group (group IV, n = 2) were used as controls. Self-secreted extracellular matrix was used as cellular carrier. Radiographic and histomorphometric examination demonstrated more callus in the bone defects of group I compared to other groups. Week 24 after implantation, the defect healing rates of groups I, II, III, and IV were 6/7, 1/5, 2/5, and 0/2, respectively. The maximum compressive strength of new tissue in the bone defects of group I was higher than those of groups II and III. Temporary cellular and persistent humoral immune responses against adenovirus were detected after hBMP-2 gene transfer. We found that Adv-hBMP-2 genetransduced BMSCs had superior osteoinductivity in the repair of tibial bone defects in goats, but it could cause temporary cellular and persistent humoral immune responses against adenovirus.Keywords
This publication has 34 references indexed in Scilit:
- Ex vivo gene therapy in autologous bone marrow stromal stem cells for tissue-engineered maxillofacial bone regenerationGene Therapy, 2003
- Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectorsGene Therapy, 2003
- Osteogenesis in rats induced by a novel recombinant helper‐dependent bone morphogenetic protein‐9 (BMP‐9) adenovirusThe Journal of Gene Medicine, 2003
- Gene Therapy of Bone Morphogenetic Protein for Periodontal Tissue EngineeringThe Journal of Periodontology, 2003
- Enhancement of Bone Healing Based onEx VivoGene Therapy Using Human Muscle-Derived Cells Expressing Bone Morphogenetic Protein 2Human Gene Therapy, 2002
- Stimulation of Smad1 Transcriptional Activity by Ras-Extracellular Signal-Regulated Kinase Pathway: A Possible Mechanism for Collagen-Dependent Osteoblastic DifferentiationJournal of Bone and Mineral Research, 2002
- Specific Depletion of Human Anti-adenovirus Antibodies Facilitates Transduction in an in Vivo Model for Systemic Gene TherapyMolecular Therapy, 2001
- Gene Therapy-Directed Osteogenesis: BMP-7-Transduced Human Fibroblasts Form Bonein VivoHuman Gene Therapy, 2000
- Cellular Immune Responses of Healthy Individuals to Intradermal Administration of an E1-E3-Adenovirus Gene Transfer VectorHuman Gene Therapy, 1999
- Biosynthetic Bone GraftingClinical Orthopaedics and Related Research, 1999